Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
Access all of the press releases and statements related to the work of the Vaccine Alliance
7 June 2018
Gavi Board approves funding for inactivated poliovirus vaccine until 2020
23 May 2018
Gavi's response to the DRC Ebola outbreak
21 May 2018
Ebola vaccine to help tackle DRC outbreak
19 May 2018
Gavi welcomes call for coordinated global action against cervical cancer
Immunisation at the 71st World Health Assembly
9 May 2018
IFPW and Gavi expand leadership training for a stronger supply chain
7 May 2018
Largest cholera vaccine drive in history to target spike in outbreaks
New management training for immunisation leaders kicks-off in Kigali
2 May 2018
Cervical cancer vaccine introduced in Zimbabwe
18 April 2018
United Arab Emirates to host Gavi 2018 mid-term review
3 April 2018
New typhoid vaccine to receive Gavi support
23 March 2018
U.S. approves $290 million for Gavi in fiscal year 2018 appropriations omnibus